Here are relevant reports on : cardiac-monitoring-market
-
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) & Region - Global Forecast to 2029
The global cardiac monitoring & cardiac rhythm management devices market, valued at US$20.7 billion in 2023, stood at US$21.3 billion in 2024 and is projected to advance at a resilient CAGR of 4.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.4 billion by the end of the period. Market growth in the Asia Pacific can be attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking, and rising morbidity and mortality from CVD.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Cardiovascular Devices Market by Product (Cardiac Imaging, Rhythm Management, Cardiac Assist Devices, Interventional Cardiology, Electrophysiology, Monitoring ), Indication (CAD, MI, CHF), End User (Hospitals & Clinics) - Global Forecast to 2029
The global cardiovascular devices market, valued at US$72.83 billion in 2023, stood at US$77.71 billion in 2024 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2029, culminating in a forecasted valuation of US$110.39 billion by the end of the period. The growth of the cardiovascular devices market is primarily due to the increasing prevalence of CVD, the aging population, and the growing prevalence of risk factors like diabetes, hypertension, obesity, and sedentary lifestyle.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, blood pressure monitors, ECG, ICP, weight Monitoring), User, Customer Unmet Needs & Region - Global Forecast to 2029
The global patient monitoring devices market, valued at US$45.7 billion in 2022, stood at US$48.5 billion in 2024 and is projected to advance at a resilient CAGR of 8.0% from 2024 to 2029, culminating in a forecasted valuation of US$71.1 billion by the end of the period. This growth is driven by factors such as the increasing prevalence of chronic disorders, an aging population, advancements in healthcare technology, and the rising adoption of wireless monitoring devices.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025
European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) & Region - Global Forecasts to 2024
The cardiac resynchronization therapy market is projected to reach USD 5.1 billion by 2024, at a CAGR of 4.4%. The growth of the Cardiac Resynchronization Therapy Market is majorly driven by the increasing incidence of target diseases (primarily due to the rising geriatric population). Rising investments and support, along with technological advancements, are also contributing to the growth of this market. Prominent players in the Cardiac Resynchronization Therapy Market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Pressure Monitoring Market by Product (Oximeters, BP Cuffs, BP Monitors (Digital, Aneroid, Cuffless)), Procedure (Invasive & Non-invasive), Therapeutic Application (Respiratory and Cardiac Disorders, Glaucoma), End User - Global Forecast to 2032
The global pressure monitoring market, valued at US$13.63 billion in 2024, stood at US$14.56 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2032, culminating in a forecasted valuation of US$ 25.48 billion by the end of the period. The pressure monitoring market is experiencing significant growth driven by medical, technological, and demographic factors.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Europe Remote Patient Monitoring (RPM) Market By Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio), End User - Forecast to 2030
Europe Remote Patient Monitoring (RPM) market, valued at US$6.16 billion in 2024, stood at US$6.87 billion in 2025 and is projected to advance at a resilient CAGR of 10.3% from 2024 to 2030, culminating in a forecasted valuation of US$11.22 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Capnography Equipment Market by Product (Multiparameter, Standalone, Software, Accessories), Technology (Mainstream, Sidestream, Microstream), Application (Cardiac Care, Respiratory Monitoring), End User (Hospitals, ASC), Region - Global Forecast to 2030
The capnography equipment market, valued at US$0.51 billion in 2024, stood at US$0.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.6% from 2024 to 2030, culminating in a forecasted valuation of US$0.67 billion by the end of the period. The capnography equipment market is expanding due to the increasing prevalence of respiratory and cardiovascular disorders, a rise in surgical procedures, and a greater focus on patient safety through continuous monitoring.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
US Remote Patient Monitoring (RPM) Market by Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User - Forecast to 2030
The US Remote Patient Monitoring (RPM) Market, valued at US$14.15 billion in 2024, stood at US$16.09 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2025 to 2030, culminating in a forecasted valuation of US$29.13 billion by the end of the period. The US remote patient monitoring industry is driven by technological innovations in FDA-approved wearable devices, mobile health applications, and monitoring solutions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cardiac Perfusion Market by Product (Oxygenation Systems, Reservoirs, Heart-Lung Machines, Arterial Filters, Heat Transfer Systems, Blood Monitoring Systems, Auto transfusion Systems) - Forecast to 2020
Cardiac perfusion systems are used to temporarily replace the functions of the heart during cardiac surgeries. The cardiac perfusion system market is broadly segmented into oxygenation systems, reservoirs, heart-lung machines, myocardial protection systems, arterial filters, blood monitoring systems, autotransfusion systems, hemoconcentrators, heat transfer systems, tubings and cannulae, and others. The pivotal factor driving the growth of this market is increasing number of cardiac surgeries. Increasing prevalence of cardiac and lung diseases in developed as well as developing further propels the growth of this market. However, insufficient number of well-trained surgeons in developing nations, unstable reimbursement policies, and competition from local players with low cost products are inhibits the growth of this market. North America is the largest market for cardiac perfusion system market, with the U.S. contributing a major share, followed by Europe, Asia-Pacific, and the Rest of the World. North America and Europe will continue to dominate the market during the forecast period owing to the growing number of cardiac and lung surgeries and technological advancement in cardiac perfusion system. However, a majority of the growth in the cardiac perfusion system market is expected to be from emerging markets in the Asia-Pacific, owing to the growing number of cardiovascular patients, increasing awareness towards healthcare, and technological advancement in cardiovascular surgery in these regions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
